Company Overview

Company name: Abacus Health Products (CNQ: ABCS)
Description: Abacus Health Products Inc is a company engaged in the development and commercialization of over-the-counter (OTC) FDA-registered topical medications which contain organic and natural ingredients, including CBD, a cannabinoid-rich hemp extract from Cannabis sativa L plant.
Year founded: 1996
Parent company:
Industry: Healthcare | Group: | Code:
Website: www.abacushp.com
Employees: 38
City: Woonsocket
State: Rhode Island
Country: United States
Region:

Financial Highlights

Start up capital raised (USD Million): 5.63
Business status: Generating Revenue
Ownership: Publicly Held
Exchange: CNQ
Ticker: ABCS
Revenue (USD Million): 11.12
Gross profit (USD Million):
Net income (USD Million) -12.12
Enterprise value: 7.25
Earnings before interest, tax, depreciation and amortization (EBITDA): -16.07
Fiscal period: TTM 3Q2019
Financing Status: The company reached a definitive agreement to be acquired by Charlotte’s Web Hemp (TSE: CWEB) for $68.2 million on March 23, 2020. This acquisition expands Charlotte’s Web’s product portfolio in the topical, personal beauty and sports categories. Previously, The company acquired Abacus Health Products through a reverse merger, resulting in the combined entity trading on the CSE Stock Exchange under the ticker symbol ABCS on January 29, 2019.
Number of active investors:
Profile last updated: 15-Apr-2020
Last known valuation:
Last known valuation date: 23-Mar-2020